Center For Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Center For Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $3,928 - $4,855	-10 Reduced 0.58%	1,714 $803,000
Q4 2023 Jan 22, 2024	SELL	$343.0 - $410.68 $410,228 - $491,173	-1,196 Reduced 40.96%	1,724 $701,000
Q3 2023 Oct 27, 2023	SELL	$338.18 - $362.46 $29,083 - $31,171	-86 Reduced 2.86%	2,920 $1.02 Million
Q2 2023 Jul 24, 2023	BUY	$314.42 - $351.91 $622,237 - $696,429	1,979 Added 192.7%	3,006 $1.06 Million
Q1 2023 Apr 24, 2023	BUY	$283.23 - $323.1 $290,877 - $331,823	1,027 New	1,027 $323,000

1,718

226M

1.21M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Center For Asset Management LLC with notifications on news.